ClinicalTrials.Veeva

Menu

Ovulation Trigger With hCG Compared to GnRH Agonist in Patients With Repeated IVF Failures

R

Rambam Health Care Campus

Status and phase

Completed
Phase 4

Conditions

Infertility

Treatments

Drug: hCG trigger
Drug: GnRH agonist trigger

Study type

Interventional

Funder types

Other

Identifiers

NCT02048891
RMB-0427-13

Details and patient eligibility

About

Ovulation trigger is needed in in vitro fertilization (IVF) to get mature eggs. Routinely, human chorionic gonadotropin (hCG) is used for that purpose given its similarity to the natural hormone that does this job in a natural cycle (luteinizing hormone, LH). In a natural cycle another hormone takes part in the process (follicle stimulating hormone, FSH). To induce a natural-like ovulation surge that includes LH and FSH , gonadotropin releasing hormone (GnRH) agonist can be given.

The purpose of this study is to find out which approach may work better in IVF patients who experienced 4 IVF failures.

Enrollment

3 patients

Sex

Female

Ages

35 to 44 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • IVF patients with at least 4 consecutive failures.
  • On trigger day, no more than 10 follicles of 12 mm and up

Exclusion criteria

  • History of moderate or severe OHSS.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

3 participants in 2 patient groups

hCG trigger
Active Comparator group
Description:
Ovulation trigger with Ovitrelle 250 microgram, luteal support with vaginal progesterone: gel Crinone 8% daily.
Treatment:
Drug: hCG trigger
GnRH agonist trigger
Experimental group
Description:
ovulation trigger with Decapeptyl 0.2 mg, luteal support with 2 injections of 1,500 U hCG.
Treatment:
Drug: GnRH agonist trigger

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems